Josh-Daniel S. Davis (joshdavis) wrote,
Josh-Daniel S. Davis
joshdavis

OH NO!

I got this letter. So sad. RISUG was a promising contraceptive that was non-surgically inserted into the vas deferens and had a rated duration of 10 years, non hormonal.


Dear Mr. Davis,

I am afraid that the publicity about RISUG has been premature and
overstated. I just returned from India wher I was informed by the
authorities that the clinical trials on RISUG had been stopped due to
failures and possible toxicity.

We at CONRAD are committed to developing new methods of contraception
and male methods are an importan focus in our preogram.

Sincerely yours,

Henry L.Gabelnick, Ph.D.
Director
CONRAD
1611 North Kent Street, Suite 806
Arlington, VA 22209 USA
tel: 1-703-276-3904
fax: 1-703-524-0770
www.conrad.org
Tags: untagged
Subscribe
  • Post a new comment

    Error

    Anonymous comments are disabled in this journal

    default userpic

    Your reply will be screened

    Your IP address will be recorded 

  • 0 comments